Teva To Sue FDA Over Pravachol Marketing Exclusivity

By Marius Meland

Law360 (July 6, 2005, 12:00 AM EDT) -- Israeli drug maker Teva Pharmaceutical Industries Ltd. said Wednesday it would sue the U.S. Food and Drug Administration over a decision that effectively wiped out the company’s marketing exclusivity for a...

To view the full article, register now.

Try Law360 FREE for seven days

Already a subscriber? Click here to login

Add to Briefcase
Printable Version
Rights/Reprints
Editorial Contacts

Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.

Listen To Our Latest

Teva To Sue FDA Over Pravachol Marketing Exclusivity

Related

Sections

Companies

Government Agencies

Most Popular

Show all interests